0001638599-20-000653.txt : 20200702
0001638599-20-000653.hdr.sgml : 20200702
20200702180649
ACCESSION NUMBER: 0001638599-20-000653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clasby Jennifer G
CENTRAL INDEX KEY: 0001728919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38365
FILM NUMBER: 201011275
MAIL ADDRESS:
STREET 1: 501 FIFTH AVENUE
STREET 2: SUITE 1404
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EYENOVIA, INC.
CENTRAL INDEX KEY: 0001682639
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471178401
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 813-766-9539
MAIL ADDRESS:
STREET 1: 295 MADISON AVENUE,
STREET 2: SUITE 2400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4_6776.xml
PRIMARY DOCUMENT
X0306
4
2020-06-30
0
0001682639
EYENOVIA, INC.
EYEN
0001728919
Clasby Jennifer G
C/O EYENOVIA, INC.
295 MADISON AVENUE, SUITE 2400
NEW YORK
NY
10017
0
1
0
0
VP, Clinical Operations
Common Stock
28965
D
Stock Option (right to buy)
2.72
2020-06-30
4
A
0
121410
0.00
A
2030-06-02
Common Stock
121410
121410
D
Stock Option (right to buy)
1.95
2027-07-07
Common Stock
51247
51247
D
Stock Option (right to buy)
6.20
2028-07-24
Common Stock
19874
19874
D
Stock Option (right to buy)
3.11
2029-08-16
Common Stock
42722
42722
D
This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
The option became exercisable as to 2,228 shares on August 7, 2017 and becomes exercisable in equal 2,228 share amounts on each of the 35 one-month anniversaries thereafter.
One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
/s/ S. Halle Vakani, Attorney-in-Fact
2020-07-02
EX-24
2
exhibit24.htm
EXHIBIT 24
Exhibit 24